Parkinson’s disease as a somato-cognitive action network disorder
Top Cited Papers
Open Access
- 4 February 2026
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 651 (8107) , 1030-1038
Abstract
Parkinson’s disease (PD) is an incurable neurological disorder that often begins insidiously with sleep disturbances and somatic symptoms, progressing to whole-body motor and cognitive symptoms1,2,3,4,5. Dysfunction of the somato-cognitive action network (SCAN)—which is thought to control action execution6,7 by coordinating arousal, organ physiology and whole-body motor plans with behavioural motivation—is a potential contributor to the diverse clinical manifestations of PD. To investigate the role of the SCAN in PD pathophysiology and treatments (medications, deep-brain stimulation (DBS), transcranial magnetic stimulation (TMS) and MRI-guided focused ultrasound stimulation (MRgFUS)), we built a large (n = 863), multimodal, multi-intervention clinical imaging dataset. Resting-state functional connectivity revealed that the substantia nigra and all PD DBS targets (subthalamic nucleus, globus pallidus and ventral intermediate thalamus) are selectively connected to the SCAN rather than to effector-specific motor regions. Importantly, PD was characterized by specific hyperconnectivity between the SCAN and the subcortex. We therefore followed six PD cohorts undergoing DBS, TMS, MRgFUS and levodopa therapy using precision resting-state functional connectivity and electrocorticography recording. Efficacious treatments reduced SCAN-to-subcortex hyperconnectivity. Targeting the SCAN instead of effector regions doubled the efficacy of TMS treatments. Focused ultrasound treatment benefits increased when the target was closer to the thalamic SCAN sweet spot. Thus, SCAN hyperconnectivity is central to PD pathophysiology and its alleviation is a hallmark of successful neuromodulation. Targeting functionally defined subcortical SCAN nodes may improve existing therapies (DBS, MRgFUS), whereas cortical SCAN targets offer effective non-invasive or minimally invasive neuromodulation for PD.Keywords
This publication has 131 references indexed in Scilit:
- Automated Imaging Differentiation for ParkinsonismJAMA Neurology, 2025
- Probabilistic Mapping of Deep Brain Stimulation: Insights from 15 Years of TherapyAnnals of Neurology, 2020
- Subthalamic Nucleus Deep Brain Stimulation Modulates 2 Distinct NeurocircuitsAnnals of Neurology, 2020
- Diagnosis and Treatment of Parkinson DiseaseJAMA, 2020
- Accurate nonlinear mapping between MNI volumetric and FreeSurfer surface coordinate systemsHuman Brain Mapping, 2018
- Motion artifact in studies of functional connectivity: Characteristics and mitigation strategiesHuman Brain Mapping, 2017
- Connectivity Predicts deep brain stimulation outcome in Parkinson diseaseAnnals of Neurology, 2017
- Basal Ganglia Circuits as Targets for Neuromodulation in Parkinson DiseaseJAMA Neurology, 2015
- History, Applications, and Mechanisms of Deep Brain StimulationJAMA Neurology, 2013
- CONTROL OF TWO SIMULTANEOUS VOLUNTARY MOTOR ACTS IN NORMALS AND IN PARKINSONISMArchives of Neurology And Psychiatry, 1954